Back to Search Start Over

DPP4‐inhibitor‐associated oral mucous membrane pemphigoid.

Authors :
Thermos, Grigorios
Katsoulas, Nikolaos
Vilos, George
I. Tosios, Konstantinos
Source :
Oral Diseases. Jul2023, Vol. 29 Issue 5, p2321-2323. 3p. 1 Color Photograph.
Publication Year :
2023

Abstract

The article presents a case report of a 71-year-old male with oral mucous membrane pemphigoid (MMP) while under treatment with vildagliptin, a dipeptidyl peptidase-IV inhibitor (DPP4i) used for type 2 diabetes. The report highlights the association between DPP4 inhibitors and autoimmune blistering disorders and suggests substituting the drug or discontinuing it to achieve remission of MMP symptoms.

Subjects

Subjects :
*DENTAL implants
*PHYSICAL diagnosis
*JAW diseases
*BIOPSY
*ERYTHEMA
*GENERIC drug substitution
*DEXAMETHASONE
*MOUTHWASHES
*BULLOUS pemphigoid
*HYPOGLYCEMIC agents
*BLISTERS
*TYPE 2 diabetes
*FLUORESCENT antibody technique
*ORAL mucosa
*DENTAL fillings
*METFORMIN
*ENZYME inhibitors
*OSSEOINTEGRATION
*ORAL manifestations of general diseases

Details

Language :
English
ISSN :
1354523X
Volume :
29
Issue :
5
Database :
Academic Search Index
Journal :
Oral Diseases
Publication Type :
Academic Journal
Accession number :
164230667
Full Text :
https://doi.org/10.1111/odi.14234
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details